Abstract
Fusion peptide (FP) of the HIV gp41 molecule inserts into the T cell membrane during virus-cell fusion. FP also blocks the TCR/CD3 interaction needed for antigen-triggered T cell activation. Here we used in vitro (fluorescence and immunoprecipitation), in vivo (T cell mediated autoimmune disease adjuvant arthritis), and in silico methods to identify the FP-TCR novel interaction motif: the α-helical transmembrane domain (TMD) of the TCR α chain, and the β-sheet 5–13 region of the 16 N-terminal aa of FP (FP1–16). Deciphering the molecular mechanism of the immunosuppressive activity of FP provides a new potential target to overcome the immunosuppressant activity of HIV, and in addition a tool for down-regulating immune mediated inflammation.—Bloch, I., Quintana, F. J., Gerger, D., Cohen, T., Cohen, I. R., and Shai, Y. T-Cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif.
| Original language | American English |
|---|---|
| Pages (from-to) | 393-401 |
| Journal | The FASEB Journal |
| Volume | 21 |
| Issue number | 2 |
| State | Published - 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver